Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe

HIV Medicine

Volumn 14, Issue 8, 2013, Pages 503-508

  Ryom, L ^a   Kirk, O ^a,b   Lundgren, Jd ^a,b   Reiss, P ^c   Pedersen, C ^d   De Wit, S ^e   Buzunova, S ^f   Gasiorowski, J ^g   Gatell, Jm ^h   Mocroft, A ⁱ  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^f Novgorod Centre for AIDS   (Russian Federation)

^g WROCLAW MEDICAL UNIVERSITY   (Poland)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Advanced chronic kidney disease; End stage renal disease; Estimated glomerular filtration rate; HIV; Kidney

Indexed keywords

ARTICLE; CAUCASIAN; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DEATH; DIABETES MELLITUS; DRUG USE; EUROPE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; INCIDENCE; KIDNEY DEATH; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PANCREATITIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; VIRUS LOAD;

ADVANCED CHRONIC KIDNEY DISEASE; END-STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; HIV; KIDNEY;

COHORT STUDIES; DISEASE PROGRESSION; EUROPE; FEMALE; GLOMERULAR FILTRATION RATE; HIV SEROPOSITIVITY; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84881314022     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12038     Document Type: Article

References (20)

1. Bickel M, Marben W, Betz C etal. End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 years. HIV Med 2012; 14: 127-135.
2. Mocroft A, Kirk O, Reiss P etal. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 2010; 24: 1667-1678.
3. Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med 2009; 10: 329-336.
4. Mocroft A, Ledergerber B, Katlama C etal. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 22-29.
5. Vrouenraets SM, Fux CA, Wit FW etal. A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. Clin Nephrol 2012; 77: 311-320.
6. Kowalska JD, Friis-Moller N, Kirk O etal. The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology 2011; 22: 516-523.
7. d'Arminio A, Sabin CA, Phillips AN etal. Cardio- and cerebrovascular events in HIV-infected persons. AIDS 2004; 18: 1811-1817.
8. Bansi L, Hughes A, Bhagani S etal. Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS 2009; 23: 2517-2521.
9. Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Am J Kidney Dis 2011; 59: 620-635.
10. Lucas GM, Mehta SH, Atta MG etal. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21: 2435-2443.
11. Bash LD, Astor BC, Coresh J. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2010; 55: 31-41.
12. Hallan SI, Coresh J, Astor BC etal. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. JASN 2006; 17: 2275-2284.
13. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008; 197: 1548-1557.
14. Foley RN, Collins AJ. The USRDS: what you need to know about what it can and can't tell us about ESRD. CJASN 2012 [Epub ahead of print].
15. Tourret J, Tostivint I, du Montcel ST etal. Outcome and prognosis factors in HIV-infected hemodialysis patients. CJASN 2006; 1: 1241-1247.
16. Mocroft A, Neuhaus J, Peters L etal. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS ONE 2012; 7: e40245.
17. Peters L, Grint D, Lundgren JD etal. HCV viremia increases the incidence of chronic kidney disease in HIV-infected patients. AIDS 2012; 26: 1917-1926.
18. O'Hare AM, Choi AI, Bertenthal D etal. Age affects outcomes in chronic kidney disease. JASN 2007; 18: 2758-2765.
19. Smith C, Sabin CA, Lundgren JD etal. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 2010; 24: 1537-1548.
20. Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin Infect Dis 2007; 45: 1625-1632.